Pharmacological modulation of secondary mediator systems–cyclic AMP and cyclic GMP–on inflammatory hyperalgesia

FQ Cunha, MM Teixera… - … journal of pharmacology, 1999 - Wiley Online Library
The objective of the present paper was to evaluate the relevance of neuronal balance of
cyclic AMP and cyclic GMP concentration for functional regulation of nociceptor sensitivity …

Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics

EJ Tsai, DA Kass - Pharmacology & therapeutics, 2009 - Elsevier
… In addition, we illustrate how cGMP signaling becomes … cGMP plays in cardiac physiology
and pathophysiology presents great opportunities for pharmacologic modulation of the cGMP

Nitric oxide and cyclic GMP signaling

LJ McDonald, F Murad - Proceedings of the Society for …, 1996 - journals.sagepub.com
… ), or from pharmacologic agents, the nitrovasodilators. NO and cGMP together comprise an
especially wide-ranging signal transduction system when one considers (i) the many roles of …

Guanylyl cyclases and signaling by cyclic GMP

KA Lucas, GM Pitari, S Kazerounian… - Pharmacological …, 2000 - ASPET
… of cGMP regulates complex signaling cascades through immediate downstream effectors,
including cGMP-dependent protein kinases, cGMP-regulated phosphodiesterases, and …

Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway

AE Eckly, C Lugnier - British journal of pharmacology, 1994 - Wiley Online Library
… which cyclic GMP modulates cyclic AMP content. In the presence of endothelium, the increase
in cyclic GMP … in cyclic AMP levels thereby allows PDE IV (low VlKm ratio) to participate in …

Regulation of gene expression by cyclic GMP

RB Pilz, DE Casteel - Circulation research, 2003 - Am Heart Assoc
Cyclic GMP signaling pathway. Cyclic GMP is synthesized by soluble guanylate cyclases in
response to NO or by receptor guanylate cyclases, which are activated by natriuretic peptides…

Pharmacologic modulators of soluble guanylate cyclase/cyclic guanosine monophosphate in the vascular system-from bench top to bedside

EB Jackson, S Mukhopadhyay… - … Vascular Pharmacology, 2007 - ingentaconnect.com
cyclic nucleotide machinery. Numerous complexes of ligands, enzymes, cofactors, and
substrates present significant targets for pharmacologic modulationCyclic GMP and cAMP may …

[PDF][PDF] Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats.

ET Iwamoto, L Marion - … of Pharmacology and Experimental Therapeutics, 1994 - Citeseer
… by an L-arginine/nitric oxide/cyclic GMP cascade. Seven days after implantation of intrathecal
… -permeable cy-clic GMP analogs, dibutyryl cyclic GMP and 8-bromo cyclic GMP, produced …

Pharmacological manipulation of cGMP and NO/cGMP in CNS drug discovery

MA Hollas, MB Aissa, SH Lee, JM Gordon-Blake… - Nitric Oxide, 2019 - Elsevier
… The activated sGC rapidly converts GTP into the second messenger 3‘,5‘-cyclic GMP (cGMP),
which, in turn, activates PKG. Through the activation of PKG, NO/cGMP signaling is …

Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system

F Murad - Advances in pharmacology, 1994 - Elsevier
… Although cyclic GMP was considered a potentially important second messenger in … role
for this cyclic nucleotide in signal transduction. The significance of cyclic GMP in cellular …